December 6, 2019

Picking on Pruritus as a Problematic Clinical Biomarker in Autoimmune Connective Tissue Diseases

Drs. Gideon P. Smith and Adam Friedman

Pruritus is the worst – plain and simple. However we have only just scratched the surface with respect to why it happens in a multitude of clinical scenarios and what it could be telling us other then “SCRATCH ME.” In this edition of the JDD Podcast, Dr. Gideon Smith, assistant professor of dermatology at Harvard Medical school, Vice Chair for Clinical Affairs in Dermatology, and Director of the Connective Tissue Diseases Clinic and Fellowship joins us to pick apart his recent study in the JDD October 2019 edition, Characterizing Pruritus in Autoimmune Connective Tissue Diseases. Tune in to learn how not all itch is created equal in the autoimmune connective tissue world. Determine what questions can help guide management and therapy selection. Hear how to connect with rheumatology to forge a long lasting partnership, just like itchy and scratchy.

 

JDD Article Referenced in this Podcast:
Yahya Argobi MD FAAD, Gideon P. Smith MD MPH PhD
J Drugs Dermatol. 2019;18(10):995-998.
A CME exam is available for this podcast.
Learning Objectives:
Upon completion of this enduring activity, participants should be able to:
  • discuss the frequency, location, severity, and timing relative to the onset of pruritus and cardiovascular diseases.
Disclosures:
Adam Friedman, MD – Menlo Therapeutics (Advisory Board)
Gideon Smith, MD MPH PhD – Menlo Therapeutics (Grant/Research Support)
Related Article